Scarica l'app Stockscreener
6.38
1.92%
0.12
Dopo l'orario di chiusura:
6.69
0.31
+4.86%
Precedente Chiudi:
$6.26
Aprire:
$6.19
Volume 24 ore:
161.72K
Relative Volume:
0.11
Capitalizzazione di mercato:
$40.30M
Reddito:
-
Utile/perdita netta:
$-11.46M
Rapporto P/E:
-0.4557
EPS:
-14
Flusso di cassa netto:
$-24.56M
1 W Prestazione:
+10.96%
1M Prestazione:
+11.54%
6M Prestazione:
+331.08%
1 anno Prestazione:
-51.30%
Intervallo 1D:
$5.74
$6.45
Intervallo di 1 settimana:
$5.5101
$6.45
Portata 52W:
$1.20
$13.15
Evaxion A S Adr Stock (EVAX) Company Profile
Confronta EVAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVAX
Evaxion A S Adr
|
6.38 | 51.97M | 0 | -11.46M | -24.56M | -14.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Evaxion A S Adr Stock (EVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-02 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | Iniziato | H.C. Wainwright | Buy |
Evaxion A S Adr Borsa (EVAX) Ultime notizie
Evaxion Biotech’s Earnings Call Highlights Strategic Growth - TipRanks
Evaxion Biotech Reports Strong Q3 2025 Results - TipRanks
Analysts Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) PT at $12.33 - Defense World
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
Evaxion raises $7.2 million, extending cash runway to second half of 2027 - GlobeNewswire Inc.
European ADRs Barely Budge While Gainers And Losers Trade Places - Finimize
Evaxion A/S (NASDAQ:EVAX) Given Buy Rating at HC Wainwright - Defense World
European ADRs Edge Higher As Healthcare Leads Gains - Finimize
Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Sees Large Growth in Short Interest - Defense World
Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough - ts2.tech
Biotech Stocks Lead European ADRs Higher On Wall Street - Finimize
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
European Pharma And Biotech Companies Led ADR Gains In The US - Finimize
Evaxion Biotech price target raised to $16 from $14 at H.C. Wainwright - MSN
Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) - The Globe and Mail
Evaxion Biotech out-licensed vaccine candidate EVX-B3 to MSDMerck - TipRanks
Evaxion A/S (NASDAQ:EVAX) Trading Down 0.7% – Should You Sell? - Defense World
Evaxion Biotech A/S Adr Earnings Call: Strategic Growth Amid Challenges - TipRanks
Evaxion Biotech Reports Q2 2025 Financial Results - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gains 2% for Week - MSN
XTX Topco Ltd Makes New Investment in Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) - Defense World
Short Interest in Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Expands By 148.8% - Defense World
Evaxion Boosts Equity through Debt Conversion, Improves Financial Flexibility - AInvest
Healthcare Stocks to Watch: Evaxion Biotech, CVRx, and Rockwell Medical Receive Bullish Sentiments - AInvest
Biotech Contrarians: Seizing Value in Europe's ADRs Amid Sectoral Slump - AInvest
European ADRs Dip As Evaxion And Grifols Climb - Finimize
European ADRs Dip While Biotech And Energy See Gains - Finimize
European ADRs Dip With Some Stocks Rising Above The Crowd - Finimize
EVAX: Grant For Polio Vaccine Announced - Research Tree
Evaxion Biotech’s Earnings Call Highlights Progress and Challenges - MSN
Evaxion Biotech Reports Q1 2025 Progress and Financials - TipRanks
European ADRs Rise On S&P Europe Select Index - Finimize
Evaxion A/S: Shareholders Board Members Managers and Company Profile | US29970R3030 - MarketScreener
European Equities See Growth In US Trade - Finimize
Evaxion A S Adr Azioni (EVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.44%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):